Autumn IPO pipeline takes shape in HK

Hong Kong Ship - resized
By John Loh
09 Aug 2018

In a quiet week for Asia’s equity capital markets, three issuers filed preliminary documents ahead of their planned share debuts in Hong Kong due to take place in the autumn.

Shanghai Junshi Biosciences is working with CICC as the sole sponsor on a possible $500m IPO.

The company develops drugs used to treat autoimmune and metabolic diseases in China. It focuses on the emerging field of immuno-oncology and is working towards the production of macromolecule drugs that target ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial